Global Cardiovascular Devices Market
Medical Equipment

Key Insights On The Cardiovascular Devices Market 2024 – Size, Driver, And Major Players | Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Cardiovascular Devices Global Market Report 2023, the cardiovascular devices market is expected to show significant growth in the forecast period.

The cardiovascular devices market has experienced robust growth, escalating from $66.15 billion in 2023 to an anticipated $72.15 billion in 2024, showcasing an impressive compound annual growth rate (CAGR) of 9.1%. This surge can be attributed to lifestyle-related diseases, an aging population, advancements in minimally invasive procedures and implantable devices, improved healthcare access, and regulatory approvals. Looking ahead, the market is set to flourish further, reaching $98.57 billion in 2028 with a CAGR of 8.1%, driven by trends such as personalized medicine, remote monitoring, artificial intelligence (AI) integration, and value-based healthcare.

Rising Prevalence of Cardiovascular Disorders

Cardiovascular Disorders on the Rise

  • The prevalence of cardiovascular disorders is a key driver for the growth of the cardiovascular device market.
  • Cardiovascular disorders encompass a range of medical conditions affecting the heart and blood vessels.
  • A surge in cardiovascular-related deaths, as seen in Singapore, highlights the global challenge.

Cardiovascular Devices Market Players

  • Key players in the cardiovascular devices market include Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, and others.

View More On The Cardiovascular Devices Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Leadless Pacemakers: A Less-Invasive Treatment

Alternative to Conventional Pacemakers

  • Leadless pacemakers offer a less-invasive alternative for conditions like bradycardia.
  • Inserted into the heart’s right ventricle without incisions, leads, or a surgical pocket, reducing complications.
  • Popular for their quick procedure (under 30 minutes) and minimal postprocedural restrictions.

Major Manufacturers

  • Medtronic and Abbott are leading the development and manufacturing of leadless pacemakers.

Cardiovascular Devices Market Segmentation

Types of Cardiovascular Devices

  1. Cardiovascular Surgery Devices And Equipment
  2. Cardiac Rhythm Management (CRM) Devices And Equipment
  3. Interventional Cardiology Devices And Equipment
  4. Defibrillator Devices And Equipment
  5. Peripheral Vascular Devices And Equipment
  6. Prosthetic Heart Valve Devices And Equipment
  7. Electrophysiology Devices And Equipment
  8. Cardiac Assist Devices And Equipment

End Users

  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Other End Users

Type of Expenditure

  • Public
  • Private

Products

  • Instruments/Equipment
  • Disposables

Regional Dominance

North America’s Leadership

  • In 2023, North America emerged as the largest region in the global cardiovascular devices market.

Request A Sample Of The Global Cardiovascular Devices Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=1972&type=smp

Conclusion
The cardiovascular devices market’s upward trajectory is indicative of a robust healthcare landscape addressing heart-related concerns. With a focus on innovative technologies, less-invasive interventions, and a comprehensive range of devices, the market is geared towards meeting the evolving needs of patients globally. The trends of wearable cardiovascular devices, bioresorbable devices, and remote consultations demonstrate the industry’s commitment to patient-centered care and sustainable solutions. As we move into the future, the cardiovascular devices market is not just growing in size but evolving in ways that promise enhanced cardiac care and improved patient outcomes.

About Company:  TBRC
As a premier market research firm, we specialize in delivering comprehensive insights into customer behavior, market trends, product landscapes, and competitor analysis. Our expertise lies in extracting actionable intelligence through methods such as secondary research, expert interviews, proprietary data, and our extensive in-house knowledge base. With a dedicated team of over 350 experts spanning 28 countries, we curate a repository of 1.5 million datasets across 27 diverse industries, including services, manufacturing, healthcare, financial services, and technology. Our tailored intelligence services empower strategic decision-making, guiding you in market selection, customer targeting, and outmaneuvering competitors.